HRTX - Heron Therapeutics GAAP EPS of -$0.55 misses by $0.05 revenue of $27.63M beats by $2.98M
- Heron Therapeutics press release ( NASDAQ: HRTX ): Q2 GAAP EPS of -$0.55 misses by $0.05 .
- Revenue of $27.63M (+23.3% Y/Y) beats by $2.98M .
- As of June 30, 2022, Heron had cash, cash equivalents and short-term investments of $83.5 million.
- Shares -5.32% PM.
For further details see:
Heron Therapeutics GAAP EPS of -$0.55 misses by $0.05, revenue of $27.63M beats by $2.98M